Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Atul Deodhar, Filip Van den Bosch, Denis Poddubnyy, Walter P. Maksymowych, Désirée van der Heijde, Tae‐Hwan Kim, Mitsumasa Kishimoto, Ricardo Blanco, Yuanyuan Duan, Yihan Li, Aileen L. Pangan, Peter Wung, In‐Ho Song
Topics & Concepts
MedicinePlaceboAnkylosing spondylitisClinical endpointInternal medicineAxial spondyloarthritisRandomized controlled trialC-reactive proteinClinical trialPhysical therapySurgeryPathologyInflammationAlternative medicineSacroiliitisSpondyloarthritis Studies and TreatmentsSpine and Intervertebral Disc PathologyRheumatoid Arthritis Research and Therapies